Harrison Pope

Harrison Pope's AcademicInfluence.com Rankings

Harrison Pope

Biology

#3898

World Rank

#5896

Historical Rank

#1532

USA Rank

biology Degrees

Download Badge

Biology

Why Is Harrison Pope Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Harrison Graham "Skip" Pope, Jr. , is an American professor and physician, currently Professor of Psychiatry at Harvard Medical School and an attending physician at McLean Hospital. He is also the Director, Biological Psychiatry Laboratory at McLean's. According to the ISI index, he is one of the most highly cited psychiatrists of the 20th century. Pope's research focus is on substance abuse, especially anabolic steroids, marijuana, hallucinogens, and MDMA. In his book the Adonis Complex, he argues that the media fuels body image disorders for not only women but men as well. He has also written extensively about repressed memory and recovered memory controversy, arguing that repressed memory does not exist. Pope has been a pioneer in designing the first randomized clinical trials of several currently accepted treatments for psychiatric disorders.

(See a Problem?)

Harrison Pope's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication (2007) (4298)
The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. (1992) (1609)
The Adonis Complex: The Secret Crisis of Male Body Obsession (2000) (741)
Muscle dysmorphia. An underrecognized form of body dysmorphic disorder. (1997) (689)
Neuropsychological performance in long-term cannabis users. (2001) (660)
A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder (2000) (643)
Compulsive buying: a report of 20 cases. (1994) (629)
Biceps and Body Image: The Relationship Between Muscularity and Self-Esteem, Depression, and Eating Disorder Symptoms. (2004) (604)
Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. (1978) (590)
Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. (1994) (575)
Evolving ideals of male body image as seen through action toys. (1999) (574)
The residual cognitive effects of heavy marijuana use in college students. (1996) (553)
Cultural expectations of muscularity in men: the evolution of playgirl centerfolds. (2001) (539)
Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. (2000) (538)
Early-onset cannabis use and cognitive deficits: what is the nature of the association? (2003) (526)
Body image in boys: a review of the literature. (2001) (510)
Comorbidity of fibromyalgia with medical and psychiatric disorders. (1992) (505)
Body dysmorphic disorder: 30 cases of imagined ugliness. (1993) (495)
The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). II: Multi-site test-retest reliability study (1995) (478)
Anorexia nervosa and "reverse anorexia" among 108 male bodybuilders. (1993) (450)
Affective and psychotic symptoms associated with anabolic steroid use. (1988) (450)
Body image perception among men in three countries. (2000) (432)
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. (2014) (426)
Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. (1992) (424)
Muscle dysmorphia in male weightlifters: a case-control study. (2000) (405)
The media's representation of the ideal male body: a cause for muscle dysmorphia? (2002) (395)
The validity of DSM-III borderline personality disorder. A phenomenologic, family history, treatment response, and long-term follow-up study. (1983) (393)
Valproatereatment of Acute Mania: A Placebo-Controlled (1991) (373)
Bulimia treated with imipramine: a placebo-controlled, double-blind study. (1983) (318)
Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. (1985) (315)
Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? (2008) (314)
Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. (2003) (314)
Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. (1986) (295)
Phenomenologic relationship of eating disorders to major affective disorder (1983) (288)
Fluoxetine-induced akathisia: clinical and theoretical implications. (1989) (276)
Clinical features of muscle dysmorphia among males with body dysmorphic disorder. (2005) (271)
Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? (1990) (259)
Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder. (2010) (240)
Family History Study of Anorexia Nervosa and Bulimia (1983) (239)
A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. (1994) (237)
Co-occurrence of binge eating disorder with psychiatric and medical disorders. (2008) (231)
Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study (2004) (228)
Anabolic-androgenic steroid dependence: an emerging disorder. (2009) (227)
Eating disorders in college men. (1995) (225)
Treatment of depression in bipolar disorder: new directions for research. (1993) (225)
Pathological gambling and major affective disorder: preliminary findings. (1986) (223)
Illicit anabolic–androgenic steroid use (2010) (216)
The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. (2014) (213)
Is childhood sexual abuse a risk factor for bulimia nervosa? (1992) (211)
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. (2000) (210)
Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. (1998) (208)
Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. (1995) (204)
Treatment of bulimia with bupropion: a multicenter controlled trial. (1988) (204)
Risk factors for neuroleptic malignant syndrome. A case-control study. (1989) (198)
Family study of affective spectrum disorder. (2003) (197)
Response of cluster headache to psilocybin and LSD (2006) (192)
Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? (1995) (188)
Male body image in Taiwan versus the West: Yanggang Zhiqi meets the Adonis complex. (2005) (187)
Management of congenital fourth branchial arch anomalies: a review and analysis of published cases. (2009) (185)
A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. (1987) (185)
Body image and attitudes toward male roles in anabolic-androgenic steroid users. (2006) (182)
Valproate in the treatment of acute mania. A placebo-controlled study. (1991) (181)
Abstinence symptoms during withdrawal from chronic marijuana use. (2000) (180)
Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. (1991) (179)
Hallucinogen persisting perception disorder: what do we know after 50 years? (2003) (177)
Bulimia related to affective disorder by family history and response to the dexamethasone suppression test. (1982) (177)
Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use (2017) (176)
Kleptomania: a report of 20 cases. (1991) (173)
Binge-eating disorder as a distinct familial phenotype in obese individuals. (2006) (170)
Cognitive Measures in Long‐Term Cannabis Users (2002) (169)
Fat-free mass index in users and nonusers of anabolic-androgenic steroids. (1995) (168)
Fathers have lower salivary testosterone levels than unmarried men and married non-fathers in Beijing, China (2006) (165)
The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders. (1992) (165)
"Schizoaffective disorder": an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. (1980) (164)
Valproate in the Treatment of Bipolar Disorder: Literature Review and Clinical Guidelines (1992) (163)
Anabolic steroid users' attitudes towards physicians. (2004) (162)
Are impulse-control disorders related to bipolar disorder? (1996) (158)
Prevalence of anorexia nervosa and bulimia in three student populations (1984) (155)
Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole (2010) (155)
Sensitization, kindling, and anticonvulsants in mania. (1989) (152)
The residual neuropsychological effects of cannabis: the current status of research. (1995) (151)
Long-Term Anabolic-Androgenic Steroid Use Is Associated With Left Ventricular Dysfunction (2010) (148)
Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder"? (1989) (148)
Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. (2004) (148)
Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. (2003) (146)
Progressive ventricular enlargement in schizophrenia: Comparison to bipolar affective disorder and correlation with clinical course (1990) (146)
Pharmacologic treatment of binge eating disorder. (2003) (145)
Lack of hippocampal volume change in long-term heavy cannabis users. (2005) (140)
Psychological and Cognitive Effects of Long-Term Peyote Use Among Native Americans (2005) (139)
Treatment of Compulsive Shopping with Antidepressants: a Report of Three Cases (1991) (137)
Violence toward women and illicit androgenic-anabolic steroid use. (1994) (137)
Is PTSD caused by traumatic stress? (2007) (137)
Familiality and heritability of binge eating disorder: results of a case-control family study and a twin study. (2008) (136)
Muscle dysmorphia: a new syndrome in weightlifters (2002) (134)
Anorexia nervosa and bulimia among 300 suburban women shoppers. (1984) (133)
Family study of fibromyalgia and affective spectrum disorder (2004) (128)
A controlled family history study of bulimia (1987) (125)
Can memories of childhood sexual abuse be repressed? (1995) (125)
The relationship between fibromyalgia and major depressive disorder. (1996) (125)
Risk Factors for Illicit Anabolic-Androgenic Steroid Use in Male Weightlifters: A Cross-Sectional Cohort Study (2012) (124)
Impaired attention in depressive states: a non-specific deficit? (1996) (123)
The residual neuropsychological effects of cannabis: the current status of research (1995) (122)
History and epidemiology of anabolic androgens in athletes and non-athletes (2017) (121)
Anabolic-androgenic steroids as a gateway to opioid dependence. (2000) (120)
Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys (2017) (118)
Lack of Insight in Bipolar Disorder The Acute Manic Episode (1995) (118)
Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? (2003) (117)
Homicide and near-homicide by anabolic steroid users. (1990) (117)
A Critical Review of Magnetic Resonance Spectroscopy Studies of Obsessive-Compulsive Disorder (2013) (115)
MDMA ("Ecstasy") abuse and high-risk sexual behaviors among 169 gay and bisexual men. (2000) (111)
Evidence for a sex-specific residual effect of cannabis on visuospatial memory. (1997) (110)
Apparent neuroleptic malignant syndrome with clozapine and lithium. (1986) (107)
Sodium valproate: its use in primary psychiatric disorders. (1987) (107)
Drug use and life style among college undergraduates: a 30-year longitudinal study. (2001) (105)
Hallucinogens on the Internet: a vast new source of underground drug information. (2001) (105)
Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia (1983) (104)
Do patients use marijuana as an antidepressant? (1996) (103)
Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. (2009) (102)
The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. (1996) (101)
Anabolic steroid abuse among teenage girls: an illusory problem? (2007) (99)
Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? (2009) (99)
Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. (2015) (98)
Attributes of long-term heavy cannabis users: a case–control study (2003) (98)
Elevated antidepressant plasma levels after addition of fluoxetine. (1989) (96)
Lack of Insight in Psychotic and Affective Disorders: A Review of Empirical Studies (1994) (95)
Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. (2010) (95)
Is postictal electrical silence a predictor of response to electroconvulsive therapy? (1996) (94)
Management of Congenital Third Branchial Arch Anomalies: A Systematic Review (2010) (94)
The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. (1994) (93)
Antidepressant treatment of bulimia: a two-year follow-up study. (1985) (92)
Body Image Disorders and Abuse of Anabolic-Androgenic Steroids Among Men. (2017) (92)
A placebo-controlled study of trazodone in bulimia nervosa. (1989) (92)
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. (2011) (91)
Residual neuropsychologic effects of cannabis (2001) (90)
Frequency and presentation of neuroleptic malignant syndrome: a prospective study. (1987) (89)
Kleptomania: clinical characteristics and associated psychopathology (1991) (89)
Cannabis, cognition, and residual confounding. (2002) (88)
A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity. (2010) (88)
Questionable validity of ‘dissociative amnesia’ in trauma victims (1998) (87)
Bulimia in Obese Individuals: Relationship to Normal‐Weight Bulimia (1988) (87)
Anabolic-Androgenic Steroid Use Among 1,010 College Men. (1988) (87)
Binge eating disorder: a stable syndrome. (2006) (87)
Cognitive deficits in long-term anabolic-androgenic steroid users. (2013) (86)
The Cross-Sectional Cohort Study: An Underutilized Design (2005) (86)
By how much will the proposed new DSM-5 criteria increase the prevalence of binge eating disorder? (2012) (84)
Valproate in the treatment of rapid-cycling bipolar disorder. (1988) (83)
Role of Antiepileptic Drugs in the Management of Eating Disorders (2009) (81)
Marijuana use among adolescents. (2002) (81)
Prevalence of anorexia nervosa and bulimia among young diabetic women. (1985) (80)
Muscle dysmorphia. (1997) (79)
Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. (2009) (76)
Anabolic-androgenic steroid use among 133 prisoners. (1996) (76)
Family study of the aggregation of eating disorders and mood disorders (2003) (73)
An empirical study of psychosis in borderline personality disorder. (1985) (73)
Declining frequency of neuroleptic malignant syndrome in a hospital population. (1991) (71)
Failure to find evidence of schizophrenia in first-degree relatives of schizophrenic probands. (1982) (71)
Prevalence of eating disorders in middle-aged women. (2014) (70)
Duloxetine in the treatment of irritable bowel syndrome: an open‐label pilot study (2009) (70)
Illicit use of androgens and other hormones: recent advances (2012) (70)
Attributes of heavy vs. occasional marijuana smokers in a college population (1995) (69)
Factitious psychosis: phenomenology, family history, and long-term outcome of nine patients. (1982) (68)
Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. (2015) (68)
Head injury, bipolar disorder, and response to valproate. (1988) (68)
A controlled study of phenomenology and family history in outpatients with bulimia nervosa. (1990) (68)
The Psychobiology of bulimia (1987) (68)
Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients. (1982) (68)
Do hallucinogens cause residual neuropsychological toxicity? (1999) (66)
Human growth hormone abuse in male weightlifters. (2011) (66)
Performance-enhancing drugs on the web: a growing public-health issue. (2013) (65)
Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. (2011) (64)
Ruptured Tendons in Anabolic-Androgenic Steroid Users (2015) (64)
Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. (2010) (63)
Parallel-Group Placebo-Controlled Trial of Testosterone Gel in Men With Major Depressive Disorder Displaying an Incomplete Response to Standard Antidepressant Treatment (2010) (63)
Management of a case of neuroleptic malignant syndrome with bromocriptine. (1983) (61)
Is bulimia associated with borderline personality disorder? A controlled study. (1987) (60)
Antidepressant drug therapy for bulimia: current status. (1986) (60)
Is dissociative amnesia a culture-bound syndrome? Findings from a survey of historical literature (2006) (60)
Why do young women diet? The roles of body fat, body perception, and body ideal. (2001) (59)
A Placebo-Controlled Trial of Acetyl-L-Carnitine and &agr;-Lipoic Acid in the Treatment of Bipolar Depression (2013) (58)
Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline. (1985) (58)
Compulsive weight lifting and anabolic drug abuse among women rape victims. (1999) (58)
Neuroleptic malignant syndrome (1991) (57)
Testosterone supplementation for depressed men: current research and suggested treatment guidelines. (2007) (57)
Body dysmorphic disorder: does it have a psychotic subtype? (1993) (57)
National Athletic Trainers' Association position statement: anabolic-androgenic steroids. (2012) (57)
Attitudes toward DSM-IV dissociative disorders diagnoses among board-certified American psychiatrists. (1999) (56)
Pharmacological treatment of kleptomania and bulimia nervosa. (1989) (56)
Lycanthropy: alive and well in the twentieth century (1988) (55)
Does childhood sexual abuse cause fibromyalgia? (1995) (55)
Neuroleptic malignant syndrome: long-term follow-up of 20 cases. (1991) (54)
Psychiatric Effects of Anabolic Steroids (1992) (54)
The menopausal transition--a possible window of vulnerability for eating pathology. (2013) (54)
Dr. Pope and Associates Reply (1983) (53)
Good sleep, bad sleep: A meta-analysis of polysomnographic measures in insomnia, depression, and narcolepsy (1992) (52)
Does childhood sexual abuse cause adult psychiatric disorders? Essentials of methodology (1995) (51)
Nalbuphine hydrochloride dependence in anabolic steroid users. (1999) (51)
BRIEF COMMUNICATION: Bulimia in Men: A Series of Fifteen Cases (1986) (51)
Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers (2008) (48)
Drug use and life style among college undergraduates in 1989: a comparison with 1969 and 1978. (1990) (48)
Childhood sexual abuse and bulimia nervosa: a comparison of American, Austrian, and Brazilian women. (1994) (48)
Drug use history and criminal behavior among 133 incarcerated men. (1997) (48)
Assessing the subjective effects of stimulants in casual users; A methodology and preliminary results (1978) (47)
Treatment of bulimia and rapid-cycling bipolar disorder with sodium valproate: a case report. (1985) (47)
Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study. (2004) (46)
Testosterone Gel Replacement Improves Sexual Function in Depressed Men Taking Serotonergic Antidepressants: A Randomized, Placebo-Controlled Clinical Trial (2011) (46)
Psychosis in Anorexia Nervosa and Bulimia (1984) (46)
Do "flashbacks" represent obsessional imagery? (1994) (46)
Lymphocytic-choriomeningitis-virus infection traced to a pet hamster. (1974) (46)
An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive–Compulsive Disorder (2015) (46)
Possible synergism between fluoxetine and lithium in refractory depression. (1988) (45)
Clinical and theoretical implications of a possible link between obsessive-compulsive and impulse control disorders (1993) (43)
Gods, men, and muscle dysmorphia. (2011) (43)
Are eating disorders associated with borderline personality disorder? a critical review (1989) (43)
Eating disorders in hospitalized substance abusers. (1992) (42)
Valproate in psychiatric disorders: literature review and clinical guidelines. (1989) (42)
Neuropsychological aspects of lack of insight in bipolar disorder: A preliminary report (1996) (41)
REDUCED DISGUST PROPENSITY IS ASSOCIATED WITH IMPROVEMENT IN CONTAMINATION/WASHING SYMPTOMS IN OBSESSIVE-COMPULSIVE DISORDER. (2015) (41)
Eating Disorder and Socioeconomic Class: Anorexia Nervosa and Bulimia in Nine Communities (1987) (41)
Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan. (1985) (40)
Lecithin in mania: a preliminary report. (1980) (40)
A Structural Approach to the Familial Coaggregation of Disorders (2008) (39)
Polysomnographic characteristics of schizophrenia in comparison with mania and depression (1993) (38)
Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital. (1989) (38)
Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders. (1994) (38)
A study of DSM-III schizophreniform disorder. (1982) (37)
Use of an Individual-Level Approach to Identify Cortical Connectivity Biomarkers in Obsessive-Compulsive Disorder. (2019) (37)
Pathological eating and body dissatisfaction in middle-aged and older women (2014) (37)
Altered regional blood volume in chronic cannabis smokers. (2006) (37)
Changes in lipoprotein-lipid levels in normal men following administration of increasing doses of testosterone cypionate. (1996) (36)
A Supplemental Interview for Forms of “Affective Spectrum Disorder” (1991) (36)
Correlates of antimanic response to valproate. (1991) (36)
Clinical use of the radioreceptor assay for neuroleptics (1980) (35)
Treatment of Anorexia Nervosa with Antidepressants (1985) (35)
The dissimulating disorders: a single diagnostic entity? (1985) (35)
Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram (2017) (35)
Antidepressant treatment of binge-eating disorder: research findings and clinical guidelines. (1996) (35)
Axis II comorbidity of normal-weight bulimia. (1990) (34)
Body fat perception in eating-disordered men. (2004) (34)
Is bulimia nervosa a heterogeneous disorder? Lessons from the history of medicine (1988) (34)
Treatment of bulimia with antidepressants: theoretical considerations and clinical findings. (1983) (34)
Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response. (2014) (33)
Antidepressant Treatment of Bulimia: Preliminary Experience and Practical Recommendations (1983) (32)
The Health Threat Posed by the Hidden Epidemic of Anabolic Steroid Use and Body Image Disorders Among Young Men. (2018) (32)
Cannabis Psychotic Disorder (1994) (32)
Sleep EEG in bulimia (1987) (31)
The price of a gift: an approach to receiving gifts from patients in psychiatric practice. (2007) (31)
Multivariate logistic regression for familial aggregation of two disorders. II. Analysis of studies of eating and mood disorders. (2001) (31)
Phenomenology and family history of affective disorder in Cushing's disease. (1987) (31)
Very long-term users of marijuana in the United States: a pilot study. (1997) (31)
Ephedrine abuse among 36 female weightlifters. (1998) (31)
Electrophysiologic abnormalities in bulimia and their implications for pharmacotherapy: A reassessment (1989) (30)
Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia? (2019) (30)
Assessment of attentional bias and mood in users and non-users of anabolic-androgenic steroids. (1995) (29)
Does Fluoxetine Prolong Electrically Induced Seizures? (1989) (29)
Second to fourth digit ratios, sex differences, and behavior in Chinese men and women (2009) (28)
Body Ideals in Young Samoan Men: A Comparison with Men in North America and Europe (2002) (28)
Eating disorder symptoms in middle-aged and older men. (2016) (28)
Canadian and American Psychiatrists' Attitudes toward Dissociative Disorders Diagnoses (2001) (28)
Tabernanthe iboga: an African narcotic plant of social importance (1969) (27)
Cannabis and motor function: fMRI changes following 28 days of discontinuation. (2008) (27)
Treatment of Bulimia Nervosa with Trazodone: Short‐Term Response and Long‐Term Follow‐Up (1989) (27)
Eating disorders in Austrian men : An intracultural and crosscultural comparison study (1997) (27)
Testosterone levels and mental rotation performance in Chinese men (2007) (26)
Structural change in dopamine D2 receptor gene in a patient with neuroleptic malignant syndrome. (1995) (26)
Biological Treatments of Eating Disorders (2013) (26)
LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER. (2016) (25)
Schizophrenic individuals with bipolar first-degree relatives: analysis of two pedigrees. (1990) (25)
Body-image dissatisfaction in gay versus heterosexual men: is there really a difference? (2004) (25)
A Survey of American Psychiatrists' Attitudes Toward Classic Hallucinogens (2018) (25)
Public health impact of androgens (2018) (25)
Migration and manic-depressive illness. (1983) (24)
Drug use and life-style among college undergraduates. Nine years later. (1981) (24)
Family History Study of Anorexia Nervosa and Bulimia (1983) (23)
Drug use and life-style among 500 college undergraduates. (1972) (23)
Associations of anabolic-androgenic steroid use with other behavioral disorders: an analysis using directed acyclic graphs (2018) (22)
Can Individuals "Repress" Memories of Childhood Sexual Abuse? An Examination of the Evidence (1995) (22)
Lycanthropy and Self‐Identification (1990) (22)
The epidemiology of ipecac abuse. (1986) (21)
Epidemiology of Neuroleptic Malignant Syndrome (1991) (21)
Distinguishing bipolar disorder from schizophrenia in clinical practice: guidelines and case reports. (1983) (21)
Eye movement desensitization and reprocessing in eating disorders: caution against premature acceptance. (1998) (19)
Anabolic–Androgenic Steroids (2012) (18)
Drug abuse and psychopathology. (1979) (18)
Bulimia and major affective disorder: experience with 105 patients (1988) (18)
Antidepressant treatment of bulimia (1985) (17)
Anabolic-androgenic steroid-induced mental status changes. (1990) (17)
Body Image among Ariaal Men from Northern Kenya (2005) (17)
Undiagnosed vomiting in an older woman: unsuspected bulimia. (1984) (17)
Treatment of psychiatric disorders with valproate: a series of 73 cases (1988) (17)
Standards for informed consent in recovered memory therapy. (2001) (16)
"Atypical" neuroleptic malignant syndrome and the spectrum of malignant cerebrotoxic syndromes. (2007) (16)
Genetic epidemiology of eating disorders and co-occurring conditions: the role of endophenotypes. (2007) (15)
White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study (2017) (15)
Competitive Bodybuilding: Fitness, Pathology, or Both? (2019) (15)
Recovered memories of childhood sexual abuse (1998) (15)
Polypharmacy, Infectious Diseases, Sexual Behavior, and Psychophysical Health Among Anabolic Steroid-Using Homosexual and Heterosexual Gym Patrons in San Francisco's Castro District (2017) (15)
Bulimia in the late nineteenth century: the observations of Pierre Janet (1985) (14)
Treatment of Anabolic-Androgenic Steroid Related Disorders (2014) (14)
High-dose fluoxetine: safety and efficacy in 27 cases. (1991) (14)
Evidence from prospective studies (2006) (14)
Treatment of bulimia with nomifensine. (1986) (14)
Psychosis in borderline personality disorder. (1984) (13)
Newer antidepressants in the treatment of bulimia nervosa. (1987) (13)
Review Article: Anabolic-Androgenic Steroids, Violence, and Crime: Two Cases and Literature Review. (2021) (12)
Anabolic androgenic steroid induced myocardial toxicity: an evolving problem in an ageing population (2011) (12)
The CASTRO study: Unsafe sexual behaviors and illicit drug use among gay and bisexual men who use anabolic steroids (2019) (12)
Bulimia nervosa in two cultures: a comparison of Austrian and American college students. (1995) (11)
Treatment of bulimia with antidepressants (2004) (11)
Eating Disorders in Austrian Men: An Intra-cultural and Cross-cultural Comparison Study (1996) (11)
Long-term pharmacotherapy of bulimia nervosa. (1989) (11)
Urinary free cortisol and response to the dexamethasone suppression test in bulimia: A pilot study (1987) (10)
Eosinophilia-myalgia syndrome or fibromyalgia with eosinophilia? (1993) (9)
Treatment Orientation and Associated Characteristics of North American Academic Psychiatrists (1995) (9)
Evolving Perspectives on the Public Health Burden of Eating Disorders (2018) (9)
Neuroleptic blood levels and therapeutic effect (2004) (9)
Aging male symptomatology and eating behavior (2018) (9)
"Recovered memory" therapy for eating disorders: implications of the Ramona verdict. (1996) (8)
Porcine stress syndrome: An animal model for the neuroleptic malignant syndrome? (1990) (8)
Is competitive body-building pathological? Survey of 984 male strength trainers (2020) (7)
Bulimia nervosa in Austria and the United States: a controlled cross-cultural study. (1996) (7)
Testosterone gel supplementation for men with refractory depression: a randomized placebo-controlled trial (2003) (7)
Autoinduction of hypertensive reactions by tranylcypromine (1989) (7)
Responses to ???The Psychiatrist as Mind Sweeper???: Eating Disorders and Antidepressants (1983) (7)
Disorders of eating and body image during the menopausal transition: associations with menopausal stage and with menopausal symptomatology (2021) (6)
Depressive symptoms in bulimic, depressed, and non-psychiatric control subjects. (1989) (6)
Brain Electrical Activity Mapping (BEAM) in Bulimia Nervosa (1991) (6)
Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment. (1989) (6)
Misconceptions About Anabolic-Androgenic Steroid Abuse (2012) (6)
Familial hyperkalemic periodic paralysis and bipolar disorder: a linkage and treatment study. (1984) (5)
Apparent neuroleptic malignant syndrome with clozapine and lithium (1987) (5)
Marijuana and Madness: Residual cognitive effects of long-term cannabis use (2004) (5)
Anticonvulsant response in a case of anorexia nervosa and bipolar disorder associated with right‐sided brain injury (1992) (5)
Cheater Detection Using the Unrelated Question Model (2020) (5)
Drug use and lifestyle among college students in Austria and the United States. (1997) (5)
The nature of traumatic memories. (2004) (5)
Use of anabolic-androgenic steroids: we are talking prevalence rates. (1994) (5)
Pharmacologic Treatment of Bulimia Nervosa: Research Findings and Practical Suggestions (1989) (5)
The problem of child sexual abuse. (2005) (5)
Comorbidity of Fibromyalgia with Medical and Psychiatric Disorders (1993) (5)
Treatment of bulimia: a review of current studies. (1986) (4)
Pharmacological Therapy of Bulimia Nervosa (2005) (4)
Antiepileptic Drugs in Obesity, Psychotropic-Associated Weight Gain, and Eating Disorders (2008) (4)
Anabolic-Androgenic Steroid Use and Dependence (2013) (4)
Antidepressant medication in the treatment of bulimia nervosa. (1987) (4)
Dr. Phillips and Colleagues Reply (1994) (3)
Radioreceptor assays for neuroleptic drugs and clinical research in psychiatry. (1980) (3)
Bulimia in men. (1986) (3)
Autoinduction of hypertensive reactions by tranylcypromine? (1989) (3)
THE CHALLENGES OF METABOLIC SYNDROME IN EATING DISORDERS. (2020) (3)
Sexual orientation and associated characteristics among north american academic psychiatrists (1998) (3)
Abstract 3048: Chronic Anabolic Androgenic Steroid Use is Associated With Left Ventricular Systolic and Diastolic Dysfunction (2009) (3)
Psychiatric Treatment of the VIP: Some Paradoxical Risks (2012) (3)
Chronic Fatigue Syndrome (1991) (3)
Drs. Halpern and Pope Reply (2001) (2)
Response to Dr. Bowden (1984) (2)
DSM-III criteria for affective disorders and schizophrenia: a preliminary appraisal using family interview findings (1988) (2)
Debating dissociative diagnoses. (1997) (2)
Knowledge of calories and its effect on eating behavior in overweight, normal weight, and underweight individuals (1999) (2)
Abstract 18278: Anabolic-Androgenic Steroid Use is Associated With Systolic and Diastolic Left Ventricular Dysfunction (2013) (2)
Drs. Hudson and Pope Reply (1983) (2)
Effects of Heavy Marijuana Use in Students (1996) (2)
Valproate in the Treatment of Bipolar Disorder (1992) (2)
Fibromyalgia and Eosinophilia-Myalgia Syndrome (1995) (2)
Unusual flashbacks in a Vietnam veteran. (1997) (2)
Correction to: Disorders of eating and body image during the menopausal transition: associations with menopausal stage and with menopausal symptomatology (2022) (2)
Dr. Keck and Associates Reply (1988) (2)
Book Review A History of Psychiatry: From the era of the asylum to the age of Prozac By Edward Shorter. 436 pp. New York, John Wiley, 1997. $30. 0-471-15749-X (1997) (2)
Response to Letter Regarding Article, “Long-Term Anabolic-Androgenic Steroid Use Is Associated With Left Ventricular Dysfunction” (2010) (2)
Antidepressant use and risk of intubation or death in hospitalized patients with COVID-19: A retrospective cohort study of clinical effectiveness (2022) (1)
Measuring Ostracism-Induced Changes in Consumption of Palatable Food: Feasibility of a Novel Behavioral Task (2022) (1)
Glomerular Filtration Rate and Supraphysiologic-Dose Anabolic-Androgenic Steroid Use: A Cross-sectional Cohort Study. (2020) (1)
Dr. Pope and Dr. Hudson Reply (1993) (1)
Current Scientific Interest in Dissociative Amnesia: A Bibliometric Analysis (2022) (1)
Dr. McElroy and Associates Reply (1993) (1)
Prolonged impairment of sexual function associated with anabolic–androgenic steroid abuse: An underrecognized problem (2014) (1)
Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome. (1996) (1)
BODY DYSMORPHIC DISORDER : SYMPTOM OR SYNDROME. AUTHORS' REPLY (1994) (1)
Bulima treated with imipramine: a placebo controlled, double-blind study (1983) (1)
Incidence, Timing, and Factors Associated With Suicide Among Patients Undergoing Surgery for Cancer in the US. (2023) (1)
REPLY TO PARROTT (2011), FISK ET AL. (2011) AND RODGERS ET AL. (2011) (2011) (1)
Anabolic Steroid Use Disorders: Diagnosis and Treatment (2020) (1)
Dr. Hudson and Dr. Pope Reply (1991) (1)
Polysomnographic characteristics of bipolar depression (1993) (1)
Original Article A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder (2019) (1)
Long-term anabolic-androgenic steroid (AAS) Use: A possible new risk factor for early dementia (2017) (1)
Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men. (2022) (1)
Neurobiology and Treatment of Anabolic-Androgenic Steroid–Related Disorders (2021) (1)
Dr. Pope Replies (2009) (1)
Abstract 16958: Anabolic-Androgenic Steroid Use is Associated With Premature Coronary Artery Disease (2013) (1)
Frequency of the neuroleptic malignant syndrome, 1963-1986 (1987) (0)
Textbook of Biological Psychiatry (2004) (0)
RESISTANCE EXERCISE AND LEFT VENTRICULAR STRUCTURE AS ASSESSED USING CARDIAC COMPUTED TOMOGRAPHY ANGIOGRAPHY: A CONTEMPORARY REASSESSMENT OF THE MORGANROTH HYPOTHESIS (2018) (0)
Book ReviewAIDS: The ultimate challenge (1989) (0)
Dr. Fogelson and Associates Reply (1983) (0)
Anabolic-Androgenic Steroid Dependence Interview Module (2014) (0)
Bibliography for Bipolar Disorder (2003) (0)
Achieving self sufficiency in blood across Europe (1998) (0)
Genetic epidemiology, endophenotypes, and eating disorder classification. Commentaries (2007) (0)
Dr. Jonas and Associates Reply (1985) (0)
Front & Back Matter (2012) (0)
Response to R. E. Goldsmith, R. E. Cheit, & M. E. Wood, “Evidence of Dissociative Amnesia in Science and Literature: Culture-Bound Approaches to Trauma in Pope et al. (2007)” (2009) (0)
Reply to Lyvers and Hasking (2004) (2004) (0)
Subject Index Vol. 76, 2007 (2007) (0)
Neuroimaging and cognitive abnormalities in anabolic androgenic steroid abusers (2015) (0)
Fractional anisotropy increase in long-term anabolic-androgenic steroid users (2017) (0)
S-7-5 Psychiatric effects of the anabolic steroids: Aggression and impulse dyscontrol (1995) (0)
Dr. Pope and Colleagues Reply (2000) (0)
Sex Offenders (1998) (0)
CHRONIC FATIGUE SYNDROME. AUTHOR'S REPLY (1991) (0)
Contents Vol. 21, 2015 (2015) (0)
Contents Vol. 76, 2007 (2007) (0)
Book Review (2002) (0)
IFP News Section (2007) (0)
Correction to Kanayama et al. (2007). (2008) (0)
Contents, Vol. 20, Supplement 1, 1987 (1987) (0)
Ignoring Nina: Avoidance and denial in Pope, Poliakoff, Parker, Boynes, and Hudson. (2010) (0)
Book ReviewDiagnostic and Statistical Manual of Mental Disorders (1981) (0)
Dr. Hudson and Associates Reply (2006) (0)
EATING DISORDERS, BODY IMAGE, AND DRUG USE AMONG DEDICATED RESISTANCE-TRAINED FEMALES: PRELIMINARY IMPRESSIONS. (1998) (0)
COGNITIVE EFFECTS OF MARIJUANA. AUTHORS' REPLY (1996) (0)
Book Review Symptoms of Schizophrenia (Wiley Series on Personality Processes.) Edited by Charles G. Costello. New York, John Wiley, 1993. $39.95. 0-471-54875-8 (1994) (0)
College undergraduate drug use and life-styles, 1969, 1978 and 1989. (1990) (0)
14. Psychiatric effects of supraphysiologic doses of testosterone cypionate in males (1998) (0)
[The family background of bulimic women. An intercultural comparison of Austrian and American students]. (1995) (0)
Letter to the Editor (2010) (0)
The reporting of AIDS. (1989) (0)
Special focus section: Anabolic-androgenic steroids: (388092004-007) (2001) (0)
398. Neuropsychological deficits in marijuana smokers (1996) (0)
Contents of the American Journal of Psychiatry (1992) (0)
Book ReviewSchizophrenia and Affective Disorders: Biology and drug treatment (1984) (0)
Hallucinogen Treatment Measure (2018) (0)
Anabolic-Androgenic Steroid- Induced Mental Status Changes: (496332006-013) (1990) (0)
The Authors Reply (2002) (0)
Depression in Personality Disorder (1987) (0)
Marijuana Quitters Are More Aggressive: (325412004-009) (1999) (0)
Book ReviewMind-Forg'd Manacles: A history of madness in England from the Restoration to the Regency (1988) (0)
Anabolic-androgenic steroid-induced mental status changes.: (468732004-001) (1990) (0)
Cognitive Effects of Marijuana-Reply (1996) (0)

This paper list is powered by the following services:

Other Resources About Harrison Pope

en.wikipedia.org

What Schools Are Affiliated With Harrison Pope?

Harrison Pope is affiliated with the following schools:

Harvard University